Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
With respect to the ketogenic diet, Anekwe et al. (61) report on a patient with obesity who self-administered the diet (described as consuming predominantly eggs, cheese, butter, oil, nuts, leafy green vegetables and almond/coconut milk; 61) for three months; around this period, aspartate aminotransferase (AST) rose from 21 U/L to 67 U/L, alanine aminotransferase (ALT) from 18 U/L to 119 U/L, and low-density lipoprotein-cholesterol (LDL-C) from 156 mg/dL to 209 mg/dL, high-density lipoprotein-cholesterol (HDL-C) decreased from 102 mg/dL to 98 mg/dL, and a vitamin D deficiency was also noted.
Source: Safety analysis. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model
Review / evidence synthesis · Frontiers in Psychiatry · 2026
Original publication title
Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model
Copyright © 2026 Engelhardt, Ogedengbe, Millet, Ayad, Schalinski, Von Oertzen, Rieckmann, Effinger, Hirschberger, Palmer, Ede, Kraus, Trommer, Schreel, Tulipan, Way, Müller, Hull, Maes and Potenza.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Brain and body metabolic disruptions have been suggested in several studies as a mechanism underlying posttraumatic stress disorder (PTSD). Therapies targeting metabolic pathways might provide new treatment options. This review explores the potential of ketogenic therapies, such as the ketogenic diet and ketone supplementation, as novel metabolic treatments for PTSD.
Source: BackgroundAbstract: What methods does the paper describe?
An integrative review was conducted. We searched PubMed, Scopus, PsycINFO, PsycArticles, PSYNDEX, MEDLINE, ClinicalTrials.gov, International Clinical Trials Registry Platform, and EU Clinical Trials Register for clinical, preclinical, observational, mechanistic, and review studies that reported outcomes or mechanisms on the intersection of ketogenic therapy and PTSD. Methodological quality of included studies was assessed independently by two reviewers based on predefined criteria.
Source: MethodsAbstract: Discussion
Importantly, the absence of larger clinical trials and the reliance on low-level evidence substantially limit current interpretations. High-quality randomized and adequately powered clinical trials are required to examine the potential role of ketogenic therapies in treating PTSD.
Source: DiscussionAbstract: Results
Sixteen articles (9 human, 4 animal studies, 3 reviews) were eligible and included in the present review. Several metabolic and signaling pathways through which ketogenic therapies could impact PTSD pathophysiology were identified. Preclinical data suggestive of potential efficacy were identified, while only minimal reliable information is available from human studies.
Source: ResultsAuthors’ abstract
Background
Brain and body metabolic disruptions have been suggested in several studies as a mechanism underlying posttraumatic stress disorder (PTSD). Therapies targeting metabolic pathways might provide new treatment options. This review explores the potential of ketogenic therapies, such as the ketogenic diet and ketone supplementation, as novel metabolic treatments for PTSD.
Methods
An integrative review was conducted. We searched PubMed, Scopus, PsycINFO, PsycArticles, PSYNDEX, MEDLINE, ClinicalTrials.gov, International Clinical Trials Registry Platform, and EU Clinical Trials Register for clinical, preclinical, observational, mechanistic, and review studies that reported outcomes or mechanisms on the intersection of ketogenic therapy and PTSD. Methodological quality of included studies was assessed independently by two reviewers based on predefined criteria.
Results
Sixteen articles (9 human, 4 animal studies, 3 reviews) were eligible and included in the present review. Several metabolic and signaling pathways through which ketogenic therapies could impact PTSD pathophysiology were identified. Preclinical data suggestive of potential efficacy were identified, while only minimal reliable information is available from human studies.
Discussion
Importantly, the absence of larger clinical trials and the reliance on low-level evidence substantially limit current interpretations. High-quality randomized and adequately powered clinical trials are required to examine the potential role of ketogenic therapies in treating PTSD.
Publication and source details
Original title: Ketogenic therapy as a potential novel treatment approach for PTSD: an integrative review and proposed mechanistic model
Robin Engelhardt; John O. Ogedengbe; Malvina S. Millet; Mira E. G. Ayad; Inga Schalinski; Timo Von Oertzen; Anna Rieckmann; David Effinger; Simon Hirschberger; Christopher M. Palmer; Georgia Ede; Shane W. Kraus; Dominik Trommer; Louis Schreel; Julia Tulipan; Bailey Way; Roman-Ulrich Müller; Allison Hull; Jürgen Maes; Marc N. Potenza
Frontiers in Psychiatry · 2026
* Correspondence: Robin Engelhardt, robin.engelhardt@unibw.de†ORCID: Robin Engelhardt, orcid.org/0009-0006-8300-8252; John O. Ogedengbe, orcid.org/0000-0002-1559-1750; Malvina S. Millet, orcid.org/0009-0008-4869-5282; Mira E. G. Ayad, orcid.org/0009-0001-2784-6802; Inga Schalinski, orcid.org/0000-0003-1665-7640; Timo Von Oertzen, orcid.org/0000-0002-3830-235X; Anna Rieckmann, orcid.org/0000-0002-5389-1578; David Effinger, orcid.org/0000-0002-1720-1365; Simon Hirschberger, orcid.org/0000-0002-4221-7377; Christopher M. Palmer, orcid.org/0000-0001-6104-7943; Georgia Ede, orcid.org/0000-0002-5679-938X; Shane W. Kraus, orcid.org/0000-0002-0404-9480; Dominik Trommer, orcid.org/0009-0000-1423-4252; Louis Schreel, orcid.org/0000-0002-5575-2256; Julia Tulipan, orcid.org/0000-0002-7606-9499; Bailey Way, orcid.org/0000-0002-5730-2048; Roman-Ulrich Müller, orcid.org/0000-0001-6910-0745; Allison Hull, orcid.org/0009-0005-6232-0119; Jürgen Maes, orcid.org/0009-0008-2276-098X; Marc N.
Potenza, orcid.org/0000-0002-6323-1354
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:42:20.865459+00:00
DOI: 10.3389/fpsyt.2026.1854499 · PMC13598748